Aldoa-KO Mouse
一般名
Aldoa-KO
製品ID
S-KO-00991
背景情報
C57BL/6NCya
系統ID
KOCMP-11674-Aldoa-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Aldoa-KO Mouse（カタログ番号S-KO-00991）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Aldoa-KO
系統ID
KOCMP-11674-Aldoa-B6N-VA
遺伝子名
製品ID
S-KO-00991
遺伝子別名
Aldo1, Aldo-1
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conventional knockout
染色体
Chr 7
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000087566
NCBIトランスクリプトID
NM_001177307
ターゲット領域
Exon 2~10
有効領域の大きさ
~3.9 kb
遺伝子研究の概要
Aldoa, also known as aldolase A, is a crucial glycolytic enzyme. It participates in glycolysis, a metabolic pathway that breaks down glucose to produce energy in the form of ATP. Glycolysis is essential for normal cellular energy metabolism and is also significantly upregulated in many cancer cells, highlighting the importance of Aldoa in energy-related biological processes [1,2,3,5,6,8].
In various diseases, Aldoa shows distinct effects. In cancer, multiple studies indicate its oncogenic role. For instance, in colon cancer, the POU2F1-ALDOA axis enhances glycolysis and the pentose phosphate pathway, promoting cell proliferation and chemoresistance [1]. In retinoblastoma, Aldoa is overexpressed, and its knockdown reduces cell viability and induces metabolic alterations [2]. In breast cancer, an alternative splicing event in Aldoa confers tamoxifen resistance [4]. In pancreatic cancer, Aldoa inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway, promoting cancer development [9]. In addition, in vascular calcification, the orphan nuclear receptor NR4A3 enhances glycolysis by directly binding to the promoter regions of Aldoa and PFKL [5]. In contrast, in cardiomyocytes, Aldoa protects against hypoxia/reperfusion-induced apoptosis and oxidative stress by regulating the VEGF/Notch 1/Jagged 1 pathway [7].
In conclusion, Aldoa is a key glycolytic enzyme with diverse functions. Its dysregulation is involved in multiple disease conditions, especially cancer, where it often promotes tumor progression. The study of Aldoa using in vivo models, such as gene knockout or knockdown in cells and animals, has provided valuable insights into its role in these diseases, potentially paving the way for new therapeutic strategies targeting Aldoa-related pathways [1,2,4,5,6,7,8,9].
References:
1. Lin, Jinguan, Xia, Longzheng, Oyang, Linda, Zhou, Yujuan, Liao, Qianjin. 2022. The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity. In Oncogene, 41, 1024-1039. doi:10.1038/s41388-021-02148-y. https://pubmed.ncbi.nlm.nih.gov/34997215/
2. Wang, Yinghao, Tang, Junjie, Liu, Yaoming, Su, Shicai, Lu, Rong. 2024. Targeting ALDOA to modulate tumorigenesis and energy metabolism in retinoblastoma. In iScience, 27, 110725. doi:10.1016/j.isci.2024.110725. https://pubmed.ncbi.nlm.nih.gov/39262779/
3. Gao, Qiang, Zhu, Hongwen, Dong, Liangqing, Zhou, Hu, Fan, Jia. . Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. In Cell, 179, 561-577.e22. doi:10.1016/j.cell.2019.08.052. https://pubmed.ncbi.nlm.nih.gov/31585088/
4. Yu, Shiyi, Wu, Rui, Si, Yue, Dong, Weibing, Sun, Haibo. 2024. Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer. In Oncogene, 43, 2901-2913. doi:10.1038/s41388-024-03134-w. https://pubmed.ncbi.nlm.nih.gov/39164523/
5. Ma, Wenqi, Jia, Kangni, Cheng, Haomai, Zhang, Ruiyan, Yan, Xiaoxiang. 2024. Orphan Nuclear Receptor NR4A3 Promotes Vascular Calcification via Histone Lactylation. In Circulation research, 134, 1427-1447. doi:10.1161/CIRCRESAHA.123.323699. https://pubmed.ncbi.nlm.nih.gov/38629274/
6. Song, Junjiao, Li, Hongquan, Liu, Yanfang, Chen, Zhiao, He, Xianghuo. 2023. Aldolase A Accelerates Cancer Progression by Modulating mRNA Translation and Protein Biosynthesis via Noncanonical Mechanisms. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2302425. doi:10.1002/advs.202302425. https://pubmed.ncbi.nlm.nih.gov/37431681/
7. Luo, Gaiying, Wang, Rui, Zhou, Hui, Liu, Xiaoling. 2020. ALDOA protects cardiomyocytes against H/R-induced apoptosis and oxidative stress by regulating the VEGF/Notch 1/Jagged 1 pathway. In Molecular and cellular biochemistry, 476, 775-783. doi:10.1007/s11010-020-03943-z. https://pubmed.ncbi.nlm.nih.gov/33089381/
8. Kuang, Qiwen, Liang, Yuxiang, Zhuo, Yangjia, Zheng, Yu, Zhong, Weide. 2021. The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation. In OncoTargets and therapy, 14, 3353-3366. doi:10.2147/OTT.S290284. https://pubmed.ncbi.nlm.nih.gov/34079281/
9. Chen, Haidi, Ye, Zeng, Xu, Xiaowu, Ji, Shunrong, Xu, Wenyan. 2021. ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cells. In Cancer cell international, 21, 514. doi:10.1186/s12935-021-02210-5. https://pubmed.ncbi.nlm.nih.gov/34565365/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。